Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1998-04-16
1999-11-02
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4241851, 514 2, 514 8, 514 12, 514 21, A61K 3900
Patent
active
059765402
ABSTRACT:
The present invention provides compositions comprising at least one complement moiety and at least one carbohydrate moiety, and methods of producing such compositions. In particular, the compositions of the invention comprise complement proteins related to the complement receptor type 1, and further comprise ligands for intracellular molecules, such as selectins. In a preferred embodiment, the compositions comprise a complement-related protein in combination with the Lewis X antigen or the sialyl Lewis X antigen. The compositions of the invention have use in the diagnosis or therapy of disorders involving complement activity and inflammation. Pharmaceutical compositions are also provided for treating or reducing inflammation mediated by inappropriate complement activity and intercellular adhesion.
REFERENCES:
patent: 4752569 (1988-06-01), Terasaki et al.
patent: 5081034 (1992-01-01), Bevilacqua et al.
patent: 5164374 (1992-11-01), Rademacher et al.
patent: 5166133 (1992-11-01), Houston et al.
patent: 5212071 (1993-05-01), Fearon et al.
patent: 5227369 (1993-07-01), Rosen et al.
Bevilaqua et al., J. Clin. Invest., 91: 379-387 (1993).
Borman, S., Chemical & Engineering News, Dec. 7, 1992, pp. 25-28.
Brustein et al., J. Exp. Med., 176: 1415-1419 (1992).
Butcher, Eugene C., Cell, 67: 1033-1036 (Dec. 20, 1991).
Campbell et al., J. Bio. Chem., 259: 11208-11214 (1984).
Connolly et al., Neurosurgery, vol. 38 3: 523-532 (1996).
Fearon, Clin. Exp. Immunol., 86(supp. 1):43-46 (1991).
Foxall et al., J. Cell Biol., 17(4):895-902 (1992).
Goodchee et al., Bio/Technology, 9: 1347-1355 (1991).
Holme et al., Blood Reviews 3:120-129 (1989).
Howard et al., J. Bio. Chem., 262: 16830-16837 (1987).
Imai et al., Nature, 361: 555-557 (1993).
Kalli et al., J. Exp. Med., 174:1451-1460 (1990).
Kobata et al., Eur. J. Biochem., 209: 483-501 (1992).
Larsen et al., Cell, 59: 305-312 (1989).
Makrides et al., J. Bio. Chem., 267(34): 24754-24761 (1991).
Meyer et al., Clin. Exp. Immunol. 86:43-48 (1991).
Mulligan et al., J. Clin. Invest., 90: 1600-1607 (1992).
Mulligan et al., J. Immunol., 148:1479-1485 (1992).
Mulligan et al., J. Immunol., 150(6):2401-2406 (1993).
Nelson et al., J. Clin. Invest, 91: 1157-1166 (1993).
Norgard et al., Proc. Acad. Sci. USA, 90: 1068-1072 (1993).
Paulson, James C., TIBS, 14: 272-276 (1989).
Phillips et al., Science, 250: 1130-1135 (1990).
Potvin et al., J. Bio. Chem., 265(3):1515-1622 (1990).
Shandelya et al., Circulations, 87(2): 536-545 (1993).
Sharon et al., Scientific American, pp. 82-88 (Jan. 1993).
Skubitz et al., J. Immunol., 139(5): 1631-1639 (1987).
Stanley and Atkinson, J. Biol. Chem. 263:11374-11381 (1988).
Svehag, Complement Inflamm. 8:359-369 (1991).
Walz et al., Science, 250:1132-1135 (1990).
Yeh et al., J. Immunol., 146:250-256 (1990).
Stanley et al., Somatic Cell Genetics, 9(5):593-608 (1983).
Rittershaus Charles W.
Toth Carol A.
Achutamurthy Ponnathapura
T Cell Sciences, Inc.
Yankwich Leon R.
LandOfFree
Compositions comprising complement related proteins and carbohyd does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions comprising complement related proteins and carbohyd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising complement related proteins and carbohyd will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2131483